 SAN DIEGO, March 03, 2022 GLOBE NEWSWIRE -- Codex DNA, Inc. Nasdaq: DNAY, a pioneer in automated benchtop synthetic biology systems, today announced details for its first Investor RD Webinar. Management will describe the future promise of the companys RD pipeline, with a specific focus on its proprietary Short Oligo Ligation Assembly SOLA enzymatic DNA synthesis technology. 